<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    electroCore, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About electroCore, Inc.

    electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology and rheumatology. The company’s current indications are for the preventative treatment of cluster headache and acute treatment of migraine and episodic cluster headache. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $426,000,000
    • SIC CODE
      3845
    • NIN CODE
      ####
    • LEADERSHIP
      Francis R. Amato
    • FOUNDED
      2005
    • EMPLOYEES
      51-100
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    ASLAN Pharmaceuticals Limited

    ASLAN Pharmaceuticals Limited

    ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company d...

    ASLAN Pharmaceuticals is a clinical-stage oncol...

    Filing Type:    PU
    Cardiovascular Systems, Inc.

    Cardiovascular Systems, Inc.

    Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device compan...

    Cardiovascular Systems, Inc., based in St. Paul...

    Filing Type:    PU
    Axonics Modulation Technologies, Inc.

    Axonics Modulation Technologies, Inc.

    Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) is a medical technology compan...

    Axonics Modulation Technologies, Inc. (NASDAQ:A...

    Filing Type:    PU
    MISONIX, Inc.

    MISONIX, Inc.

    Misonix, Inc. (Nasdaq: MSON) designs, develops, manufactures and markets ultrasoni...

    Misonix, Inc. (Nasdaq: MSON) designs, develops,...

    Filing Type:    PU
    Cytosorbents Corporation

    Cytosorbents Corporation

    CytoSorbents Corporation (NASDAQ: CTSO) is a New Jersey-based, critical care immun...

    CytoSorbents Corporation (NASDAQ: CTSO) is a Ne...

    Filing Type:    PU
    Sientra, Inc.

    Sientra, Inc.

    Headquartered in Santa Barbara, California, Sientra is a diversified global medica...

    Headquartered in Santa Barbara, California, Sie...

    Filing Type:    PU
    Phoenix PharmaLabs Inc

    Phoenix PharmaLabs Inc

    Phoenix PharmaLabs, Inc. (PPL) is a privately held, pre-clinical stage drug develo...

    Phoenix PharmaLabs, Inc. (PPL) is a privately h...

    Amount Raised:    $1,079,375.00
    Fundraising Status:    EC
    Filing Type:    CF
    Medivie USA Inc

    Medivie USA Inc

    Medivie Therapeutic is an Israeli public company, which developed Laboraide – a ...

    Medivie Therapeutic is an Israeli public compan...

    Filing Type:    RA
    Collegium Pharmaceutical, Inc.

    Collegium Pharmaceutical, Inc.

    Collegium Pharmaceutical is a specialty pharmaceutical company committed to being ...

    Collegium Pharmaceutical is a specialty pharmac...

    Filing Type:    PU
    CymaBay Therapeutics Inc.

    CymaBay Therapeutics Inc.

    We are a clinical-stage biopharmaceutical company focused on developing and provid...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    Evelo Biosciences, Inc.

    Evelo Biosciences, Inc.

    Evelo Biosciences, Inc. is a clinical stage biotechnology company developing oral ...

    Evelo Biosciences, Inc. is a clinical stage bio...

    Filing Type:    PU
    Chiasma, Inc.

    Chiasma, Inc.

    Chiasma is focused on improving the lives of patients who face challenges associat...

    Chiasma is focused on improving the lives of pa...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.